◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Invesco Biotechnology & Genome ETF (PBE) ETF Overview
Price history, fund statistics and profile — an exchange-traded fund.
Exchange-Traded Funds · Health · DATA UPDATED 2026-08-31
Invesco Biotechnology & Genome ETF (PBE) is an exchange-traded fund managed by Invesco in the "Health" category. It manages roughly $282 million in assets.
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies.
Interactive chart & fund stats →
PBE Fund Statistics
| Expense ratio | 0.58% |
| Trailing yield | 1.73% |
| Assets under management | $282 million |
| Fund category | Health |
| Fund family | Invesco |
| Inception | 2005-06-23 |
The live price chart, fund profile and news are in the interactive PBE viewer.
Other Companies in Health
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.